FABP4 appears to be one of the most probable candidates involved in the pathophysiology of GDM [21], as well as adiposity, insulin resistance, type 2 diabetes mellitus (T2DM), atherosclerosis, hypertension, coronary artery, cerebrovascular diseases, and metabolic syndrome [22,23,24,25,26]. Here, FABP4 is linked to atherosclerosis.